Literature DB >> 17702558

Interleukin-12 and tuberculosis: an old story revisited.

Andrea M Cooper1, Alejandra Solache, Shabaana A Khader.   

Abstract

Our understanding of the role of interleukin (IL)-12 in controlling tuberculosis has expanded because of increased interest in other members of the IL-12 family of cytokines. Recent data show that IL-12, IL-23 and IL-27 have specific roles in the initiation, expansion and control of the cellular response to tuberculosis. Specifically, IL-12, and to a lesser degree IL-23, generates protective cellular responses and promotes survival, whereas IL-27 moderates the inflammatory response and is required for long-term survival. Paradoxically, IL-27 also limits bacterial control, suggesting that a balance between bacterial killing and tissue damage is required for survival. Understanding the balance between IL-12, IL-23 and IL-27 is crucial to the development of immune intervention in tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17702558      PMCID: PMC2075090          DOI: 10.1016/j.coi.2007.07.004

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  47 in total

Review 1.  IL-12p40: an inherently agonistic cytokine.

Authors:  Andrea M Cooper; Shabaana A Khader
Journal:  Trends Immunol       Date:  2006-11-28       Impact factor: 16.687

Review 2.  Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features.

Authors:  Orchidée Filipe-Santos; Jacinta Bustamante; Ariane Chapgier; Guillaume Vogt; Ludovic de Beaucoudrey; Jacqueline Feinberg; Emmanuelle Jouanguy; Stéphanie Boisson-Dupuis; Claire Fieschi; Capucine Picard; Jean-Laurent Casanova
Journal:  Semin Immunol       Date:  2006-09-25       Impact factor: 11.130

3.  Interleukin-23 restores immunity to Mycobacterium tuberculosis infection in IL-12p40-deficient mice and is not required for the development of IL-17-secreting T cell responses.

Authors:  Teresa M Wozniak; Anthony A Ryan; Warwick J Britton
Journal:  J Immunol       Date:  2006-12-15       Impact factor: 5.422

4.  Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease.

Authors:  Marc Veldhoen; Richard J Hocking; Richard A Flavell; Brigitta Stockinger
Journal:  Nat Immunol       Date:  2006-09-24       Impact factor: 25.606

5.  IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection.

Authors:  Euan Lockhart; Angela M Green; JoAnne L Flynn
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

6.  Neutralization or absence of the interleukin-23 pathway does not compromise immunity to mycobacterial infection.

Authors:  Alissa A Chackerian; Shi-Juan Chen; Scott J Brodie; Jeanine D Mattson; Terrill K McClanahan; Robert A Kastelein; Edward P Bowman
Journal:  Infect Immun       Date:  2006-08-21       Impact factor: 3.441

7.  Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system.

Authors:  Jason S Stumhofer; Arian Laurence; Emma H Wilson; Elaine Huang; Cristina M Tato; Leanne M Johnson; Alejandro V Villarino; Qiulong Huang; Akihiko Yoshimura; David Sehy; Christiaan J M Saris; John J O'Shea; Lothar Hennighausen; Matthias Ernst; Christopher A Hunter
Journal:  Nat Immunol       Date:  2006-08-13       Impact factor: 25.606

8.  Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells.

Authors:  Marcel Batten; Ji Li; Sothy Yi; Noelyn M Kljavin; Dimitry M Danilenko; Sophie Lucas; James Lee; Frederic J de Sauvage; Nico Ghilardi
Journal:  Nat Immunol       Date:  2006-08-13       Impact factor: 25.606

9.  Visualization of IL-12/23p40 in vivo reveals immunostimulatory dendritic cell migrants that promote Th1 differentiation.

Authors:  R Lee Reinhardt; Seokmann Hong; Suk-Jo Kang; Zhi-en Wang; Richard M Locksley
Journal:  J Immunol       Date:  2006-08-01       Impact factor: 5.422

10.  X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production.

Authors:  Orchidée Filipe-Santos; Jacinta Bustamante; Margje H Haverkamp; Emilie Vinolo; Cheng-Lung Ku; Anne Puel; David M Frucht; Karin Christel; Horst von Bernuth; Emmanuelle Jouanguy; Jacqueline Feinberg; Anne Durandy; Brigitte Senechal; Ariane Chapgier; Guillaume Vogt; Ludovic de Beaucoudrey; Claire Fieschi; Capucine Picard; Meriem Garfa; Jalel Chemli; Mohamed Bejaoui; Maria N Tsolia; Necil Kutukculer; Alessandro Plebani; Luigi Notarangelo; Christine Bodemer; Frédéric Geissmann; Alain Israël; Michel Véron; Maike Knackstedt; Ridha Barbouche; Laurent Abel; Klaus Magdorf; Dominique Gendrel; Fabrice Agou; Steven M Holland; Jean-Laurent Casanova
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

View more
  60 in total

Review 1.  IL-17 and Th17 cells in tuberculosis.

Authors:  Egídio Torrado; Andrea M Cooper
Journal:  Cytokine Growth Factor Rev       Date:  2010-11-12       Impact factor: 7.638

Review 2.  Striking the right immunological balance prevents progression of tuberculosis.

Authors:  Shachi Pranjal Vyas; Ritobrata Goswami
Journal:  Inflamm Res       Date:  2017-07-15       Impact factor: 4.575

3.  Diagnostic Usefulness of Cytokine and Chemokine Levels in the Cerebrospinal Fluid of Patients with Suspected Tuberculous Meningitis.

Authors:  Ji-Soo Kwon; Joung Ha Park; Ji Yeun Kim; Hye Hee Cha; Min-Jae Kim; Yong Pil Chong; Sang-Oh Lee; Sang-Ho Choi; Yang Soo Kim; Jun Hee Woo; Yong Seo Koo; Sang-Beom Jeon; Sang-Ahm Lee; Sung-Han Kim
Journal:  Am J Trop Med Hyg       Date:  2019-08       Impact factor: 2.345

4.  Essential engagement of Toll-like receptor 2 in initiation of early protective Th1 response against rough variants of Mycobacterium abscessus.

Authors:  Jong-Seok Kim; Min-Jung Kang; Woo Sik Kim; Seung Jung Han; Hong Min Kim; Ho Won Kim; Kee Woong Kwon; So Jeong Kim; Seung Bin Cha; Seok-Yong Eum; Won-Jung Koh; Sang-Nae Cho; Jong-Hwan Park; Sung Jae Shin
Journal:  Infect Immun       Date:  2015-02-02       Impact factor: 3.441

Review 5.  Innate and Adaptive Cellular Immune Responses to Mycobacterium tuberculosis Infection.

Authors:  Katrin D Mayer-Barber; Daniel L Barber
Journal:  Cold Spring Harb Perspect Med       Date:  2015-07-17       Impact factor: 6.915

6.  IL12B expression is sustained by a heterogenous population of myeloid lineages during tuberculosis.

Authors:  Allison E Reeme; Halli E Miller; Richard T Robinson
Journal:  Tuberculosis (Edinb)       Date:  2013-03-13       Impact factor: 3.131

7.  The phytochemical bergenin as an adjunct immunotherapy for tuberculosis in mice.

Authors:  Santosh Kumar; Chetan Sharma; Sandeep Rai Kaushik; Ankur Kulshreshtha; Shivam Chaturvedi; Ranjan Kumar Nanda; Ashima Bhaskar; Debprasad Chattopadhyay; Gobardhan Das; Ved Prakash Dwivedi
Journal:  J Biol Chem       Date:  2019-04-11       Impact factor: 5.157

8.  Platelets Regulate Pulmonary Inflammation and Tissue Destruction in Tuberculosis.

Authors:  Katharine A Fox; Daniela E Kirwan; Ashley M Whittington; Nitya Krishnan; Brian D Robertson; Robert H Gilman; José W López; Shivani Singh; Joanna C Porter; Jon S Friedland
Journal:  Am J Respir Crit Care Med       Date:  2018-07-15       Impact factor: 21.405

9.  Tuberculosis Infection: Insight from Immunogenomics.

Authors:  Matthew Arentz; Thomas R Hawn
Journal:  Drug Discov Today Dis Mech       Date:  2007

10.  Mycobacterium tuberculosis infection induces il12rb1 splicing to generate a novel IL-12Rbeta1 isoform that enhances DC migration.

Authors:  Richard T Robinson; Shabaana A Khader; Cynthia A Martino; Jeffrey J Fountain; Maria Teixeira-Coelho; John E Pearl; Stephen T Smiley; Gary M Winslow; David L Woodland; Michael J Walter; Jose R Conejo-Garcia; Ueli Gubler; Andrea M Cooper
Journal:  J Exp Med       Date:  2010-03-08       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.